Nalmefene Hydrochloride Oral Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 18 mg
Reference Brands: Selincro(EU)
Category:
Antipsychotropic Drugs
Nalmefene is an opioid receptor modulator that primarily acts as an antagonist at μ- and δ-opioid receptors and partial agonist at κ-opioid receptors. It reduces the rewarding effects of alcohol, helping to decrease consumption. Clinically, it's used in the management of alcohol dependence in adults with high-risk drinking behaviors.
Nalmefene Hydrochloride Oral Tablets is available in Oral Tablets
and strengths such as 18 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nalmefene Hydrochloride Oral Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nalmefene Hydrochloride Oral Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Nalmefene Hydrochloride Tablets are approved in the EU for the reduction of alcohol consumption in adult patients with alcohol dependence, under brand names like Selincro®. They are prescription-only and regulated by the European Medicines Agency (EMA) under centralized procedures. In the USA, as of now, Nalmefene tablets are not FDA-approved for alcohol dependence, though clinical trials have been conducted. EU regulatory approval includes risk management plans and post-marketing surveillance. Manufacturing requires adherence to EU-GMP guidelines. Pharmatradz.com connects you with compliant suppliers of Nalmefene Hydrochloride tablets and other psychiatric formulations for global B2B sourcing and regulatory insight.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing